Prostate cancer incidence varies among males from different Y-chromosome lineages

被引:0
作者
A A Ewis
J Lee
T Naroda
T Sano
S Kagawa
T Iwamoto
T Shinka
Y Shinohara
M Ishikawa
Y Baba
Y Nakahori
机构
[1] Health Technology Research Center,Department of Human Genetics and Public Health
[2] National Institute of Advanced Industrial Science and Technology (AIST),Department of Urology
[3] School of Medicine,Department of Pathology
[4] University of Tokushima,Department of Urology
[5] School of Medicine,Division of Gene Expression
[6] The University of Tokushima,Department of Public Health and Occupational Medicine
[7] School of Medicine,Department of Applied Chemistry
[8] The University of Tokushima,undefined
[9] School of Medicine,undefined
[10] St Marianna University,undefined
[11] Institute for Genome Research,undefined
[12] The University of Tokushima,undefined
[13] Faculty of Medicine,undefined
[14] El-Minia University,undefined
[15] Graduate School of Engineering,undefined
[16] Nagoya University,undefined
来源
Prostate Cancer and Prostatic Diseases | 2006年 / 9卷
关键词
prostate cancer; haplogroups; Y-chromosome lineages; Japanese; susceptibility;
D O I
暂无
中图分类号
学科分类号
摘要
The incidence rate of prostate cancer in African-American males is two times higher than Caucasian men and ten times higher than Japanese men. The geographical specificity of Y haplogroups implies that males from different ethnic groups undoubtedly have various Y lineages with different Y-chromosomal characteristics that may affect their susceptibility or resistance to such a male-specific cancer. To confirm this hypothesis we studied the Y-chromosomal haplogroups of 92 Japanese prostate cancer patients comparing them with randomly selected 109 unrelated healthy Japanese male controls who were confirmed to be residents of the same geographical area. Males could be classified using three binary Y-chromosome markers (sex-determining region Y (SRY), YAP, 47z) into four haplogroups DE, O2b*, O2b1, and untagged group. Our results confirmed that prostate cancer incidence varies among males from different Y-chromosome lineages. Males from DE and the untagged haplogroups are at a significantly higher risk to develop prostate cancer than O2b* and O2b1 haplogroups (P=0.01), odds ratio 2.17 and 95% confidence interval (1.16–4.07). Males from haplogroup DE are over-represented in the patient group showing a percentage of 41.3%. The underlying possible causes of susceptibility variations of different Y lineages for such a male-specific cancer tumorigenesis are discussed. These findings explain the lower incidence of prostate cancer in Japanese and other South East Asian males than other populations. To our knowledge, this is the first reliable study examining the association between prostate cancer and Y-chromosomal haplogroups, comparing prostate cancer patients with carefully selected matched controls.
引用
收藏
页码:303 / 309
页数:6
相关论文
共 213 条
  • [1] Greenlee RT(2001)Cancer statistics, 2001 CA Cancer J Clin 51 15-36
  • [2] Hill-Harmon MB(2005)Cancer statistics, 2005 CA Cancer J Clin 55 10-30
  • [3] Murray T(1999)Estimates of the worldwide incidence of 25 major cancers in 1990 Int J Cancer 80 827-841
  • [4] Thun M(1994)Descriptive epidemiology of prostate cancer in metropolitan Detroit Cancer ( 73 1704-1707
  • [5] Jemal A(1995)The geography of prostate cancer and its treatment in Japan Cancer Surv 23 267-280
  • [6] Murray T(2001)The epidemiology of prostate cancer – recent trends in prostate cancer incidence and mortality Gan To Kagaku Ryoho 28 184-188
  • [7] Ward E(1992)Mendelian inheritance of familial prostate cancer Proc Natl Acad Sci USA 89 3367-3371
  • [8] Samuels A(2003)Prostate cancer epidemiology Lancet 361 859-864
  • [9] Tiwari RC(1992)Cytogenetic analysis of 57 primary prostatic adenocarcinomas Genes Chromosomes Cancer 4 16-24
  • [10] Ghafoor A(1994)Loss and gain of chromosomes 1, 18, and Y in prostate cancer Prostate 25 281-291